Hematopoietic Stem Cell Transplantation Global Market Report 2024

Description

“Hematopoietic Stem Cell Transplantation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematopoietic stem cell transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematopoietic stem cell transplantation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hematopoietic stem cell transplantation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Allogeneic; Autologous
2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant
4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
Companies Mentioned: Pluristem Therapeutics Inc.; Lonza Group AG; Escape Therapeutics Inc.; Regen Biopharma Inc.; Bluebird Bio Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hematopoietic stem cell transplantation (HSCT) is a medical procedure employed to treat diverse blood and bone marrow disorders, including certain genetic conditions and autoimmune diseases. The process entails replacing a patient's damaged or diseased bone marrow with healthy stem cells obtained from a donor. These transplanted stem cells then grow and generate new blood cells within the patient's body. The stem cells for transplantation can be sourced from bone marrow, peripheral blood, or umbilical cord blood.

The primary types of cells used in hematopoietic stem cell transplantation are allogeneic and autologous. Allogeneic transplants involve stem cells obtained from a donor with a different genetic makeup than the recipient. This type of transplantation is applied to address conditions such as leukemia, lymphatic disorders, myeloma, and others. The applications include bone marrow transplants, peripheral blood stem cell transplants, and cord blood transplants. Hematopoietic stem cell transplantation is utilized by various end-users, including hospital pharmacies, retail pharmacies, and specialty clinics.

The hematopoietic stem cell transplantation market research report is one of a series of new reports from The Business Research Company that provides hematopoietic stem cell transplantation market statistics, including hematopoietic stem cell transplantation industry global market size, regional shares, competitors with a hematopoietic stem cell transplantation market share, detailed hematopoietic stem cell transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the hematopoietic stem cell transplantation industry. This hematopoietic stem cell transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from $4.24 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the historical period can be attributed to factors such as the development of early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, the emergence of allogeneic transplants, and regulatory milestones in the field of hematopoietic stem cell transplantation.

The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The anticipated growth in the forecast period can be attributed to expanded treatment indications, diversification of donor sources, the influence of personalized medicine and genomics, regulatory changes and updated guidelines, and increased market expansion and accessibility. Key trends expected in the forecast period encompass advancements in transplant techniques, a broader range of treatment indications, the emergence of cellular therapies, a more diverse donor pool, and the adoption of a precision medicine approach in hematopoietic stem cell transplantation.

The anticipated surge in the occurrence of blood cancer is set to drive the growth of the hematopoietic stem cell transplantation market. Blood cancers encompass a group of malignancies affecting the development and functioning of blood cells, including leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is a common treatment for these conditions, involving the replacement of stem cells and bone marrow cells damaged by the malignancy. These transplanted stem cells migrate to the bone marrow, initiating the production of new blood cells. In August 2022, Blood Cancer UK reported 41,000 identified blood cancer cases annually in the UK, making it the sixth most prevalent cancer. With an estimated 250,000 people affected in 2022, including over 500 children, the increased incidence of blood cancer drives the hematopoietic stem cell transplantation market.

The burgeoning aging population is expected to contribute to the growth of the hematopoietic stem cell transplantation market. The aging population, defined as individuals aged 65 and older, finds hematopoietic stem cell transplantation a viable treatment for various hematological disorders. As a notable example, the World Health Organization projected that globally, one in six people would be 60 or older by 2030, with the number doubling to 2.1 billion by 2050. In the UK, it is anticipated that by 2043, 24% of the total population (17.4 million people) will be seniors. Consequently, the expanding aging population propels the hematopoietic stem cell transplantation market.

Product approvals emerge as a prominent trend in the hematopoietic stem cell transplantation market, with major companies securing regulatory clearances to sustain their market positions. For instance, in April 2022, Ireland-based Priothera Ltd. received FDA clearance for an investigational new drug (IND) to initiate a Phase IIb/III research study with mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant. Mocravimod, a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, demonstrated safety and efficacy in earlier trials for various autoimmune diseases.

Major companies in the hematopoietic stem cell transplantation industry are adopting a strategic partnership approach to accelerate research and development through complementary strengths. In July 2021, US-based biotech company Vor Biopharma collaborated with Belgium-based Janssen Pharmaceutical to develop engineered hematopoietic stem cell transplants (eHSCTs) combined with a bi-specific antibody therapy for acute myeloid leukemia (AML). This partnership aims to broaden the application of eHSCT-based therapies to other cancers and blood disorders.

In August 2022, France-based Eurobio Scientific Group acquired Netherlands-based Genome Diagnostics B.V. for $132.3 million, enhancing Eurobio's commercial portfolio for evaluating compatibility in organ and marrow transplants, further solidifying its position in the hematopoietic stem cell transplantation market.

Major companies operating in the hematopoietic stem cell transplantation market report are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., NuVasive Inc., RTI Surgical Ltd., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd., 3D Biomatrix, Worthington Biochemical

North America was the largest region in the hematopoietic stem cell transplantation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hematopoietic stem cell transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hematopoietic stem cell transplantation (HSCT) market includes revenues earned by entities providing services such as medical evaluation, pre-transplant care, stem cell collection and processing, transplantation procedures, post-transplant care, supportive care, and long-term follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11784

1. Executive Summary

2. Hematopoietic Stem Cell Transplantation Market Characteristics

3. Hematopoietic Stem Cell Transplantation Market Trends And Strategies

4. Hematopoietic Stem Cell Transplantation Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Hematopoietic Stem Cell Transplantation Market Size and Growth

5.1. Global Hematopoietic Stem Cell Transplantation Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hematopoietic Stem Cell Transplantation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hematopoietic Stem Cell Transplantation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hematopoietic Stem Cell Transplantation Market Segmentation

6.1. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Allogeneic
Autologous
6.2. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Leukemia
Lymphatic Disorder
Myeloma
Other Non-Malignant Disorders
6.3. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Bone Marrow Transplant
Peripheral Blood Stem Cell Transplant
Cord Blood Transplant
6.4. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Specialty Clinics

7. Hematopoietic Stem Cell Transplantation Market Regional And Country Analysis

7.1. Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hematopoietic Stem Cell Transplantation Market

8.1. Asia-Pacific Hematopoietic Stem Cell Transplantation Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hematopoietic Stem Cell Transplantation Market

9.1. China Hematopoietic Stem Cell Transplantation Market Overview
9.2. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hematopoietic Stem Cell Transplantation Market

10.1. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hematopoietic Stem Cell Transplantation Market

11.1. Japan Hematopoietic Stem Cell Transplantation Market Overview
11.2. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hematopoietic Stem Cell Transplantation Market

12.1. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hematopoietic Stem Cell Transplantation Market

13.1. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hematopoietic Stem Cell Transplantation Market

14.1. South Korea Hematopoietic Stem Cell Transplantation Market Overview
14.2. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hematopoietic Stem Cell Transplantation Market

15.1. Western Europe Hematopoietic Stem Cell Transplantation Market Overview
15.2. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hematopoietic Stem Cell Transplantation Market

16.1. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hematopoietic Stem Cell Transplantation Market

17.1. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hematopoietic Stem Cell Transplantation Market

18.1. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hematopoietic Stem Cell Transplantation Market

19.1. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hematopoietic Stem Cell Transplantation Market

20.1. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hematopoietic Stem Cell Transplantation Market

21.1. Eastern Europe Hematopoietic Stem Cell Transplantation Market Overview
21.2. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hematopoietic Stem Cell Transplantation Market

22.1. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hematopoietic Stem Cell Transplantation Market

23.1. North America Hematopoietic Stem Cell Transplantation Market Overview
23.2. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hematopoietic Stem Cell Transplantation Market

24.1. USA Hematopoietic Stem Cell Transplantation Market Overview
24.2. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hematopoietic Stem Cell Transplantation Market

25.1. Canada Hematopoietic Stem Cell Transplantation Market Overview
25.2. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hematopoietic Stem Cell Transplantation Market

26.1. South America Hematopoietic Stem Cell Transplantation Market Overview
26.2. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hematopoietic Stem Cell Transplantation Market

27.1. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hematopoietic Stem Cell Transplantation Market

28.1. Middle East Hematopoietic Stem Cell Transplantation Market Overview
28.2. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hematopoietic Stem Cell Transplantation Market

29.1. Africa Hematopoietic Stem Cell Transplantation Market Overview
29.2. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hematopoietic Stem Cell Transplantation Market Competitive Landscape And Company Profiles

30.1. Hematopoietic Stem Cell Transplantation Market Competitive Landscape
30.2. Hematopoietic Stem Cell Transplantation Market Company Profiles
- 30.2.1. Pluristem Therapeutics Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Lonza Group AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Escape Therapeutics Inc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Regen Biopharma Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bluebird Bio Inc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Hematopoietic Stem Cell Transplantation Market Competitive Benchmarking

32. Global Hematopoietic Stem Cell Transplantation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hematopoietic Stem Cell Transplantation Market

34. Hematopoietic Stem Cell Transplantation Market Future Outlook and Potential Analysis

34.1 Hematopoietic Stem Cell Transplantation Market In 2028 - Countries Offering Most New Opportunities
34.2 Hematopoietic Stem Cell Transplantation Market In 2028 - Segments Offering Most New Opportunities
34.3 Hematopoietic Stem Cell Transplantation Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer